Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling
2019-05
发表期刊CELL PROLIFERATION
ISSN0960-7722
卷号52期号:3
发表状态已发表
DOI10.1111/cpr.12583
摘要Objectives Wnt1-inducible signalling pathway protein 3 (WISP3/CCN6) belongs to the CCN (CYR61/CTGF/NOV) family of proteins, dysregulation of this family contributed to the tumorigenicity of various tumours. In this study, we need to explore its role in hepatocellular carcinoma that remains largely elusive. Materials and Methods The expression of WISP3/CCN6 was analysed by qRT-PCR and Western blotting. Effects of WISP3 on proliferation and metastasis of HCC cells were examined, respectively, by MTT assay and Boyden Chamber. Roles of WISP3 on HCC tumour growth and metastatic ability in vivo were detected in nude mice. Related mechanism study was confirmed by immunofluorescence and Western blotting. Results The expression of WISP3 was significantly downregulated in HCC clinical samples and cell lines, and reversely correlated with the tumour size. Forced expression of WISP3 in HCC cells significantly suppressed cell growth and migration in vitro as well as tumour growth and metastatic seeding in vivo. In contrast, downregulation of WISP3 accelerated cell proliferation and migration, and promoted in vivo metastasis. Further study revealed that WISP3 inhibited the translocation of beta-catenin to the nucleus by activating glycogen synthase kinase-3 beta (GSK3 beta). Moreover, constitutively active beta-catenin blocked the suppressive effects of WISP3 on HCC. Conclusions Our study showed that WISP3 suppressed the progression of HCC by negative regulation of beta-catenin/TCF/LEF signalling, providing WISP3 as a potential therapeutic candidate for HCC.
关键词hepatocellular carcinoma metastasis tumorigenesis WISP3 beta-catenin
收录类别SCI ; SCIE
语种英语
资助项目National Natural Science Foundation of China[31520103907] ; National Natural Science Foundation of China[81730083] ; National Natural Science Foundation of China[31771538] ; National Natural Science Foundation of China[31601143]
WOS研究方向Cell Biology
WOS类目Cell Biology
WOS记录号WOS:000469271700015
出版者WILEY
WOS关键词CCN FAMILY ; E-CADHERIN ; COLORECTAL CARCINOMAS ; WNT PATHWAY ; CATENIN ; PROLIFERATION ; EXPRESSION ; GROWTH ; CELLS ; GENE
原始文献类型Article
引用统计
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/45615
专题生命科学与技术学院_特聘教授组_谢东组
生命科学与技术学院_硕士生
通讯作者Li, Jing-Jing; Xie, Dong
作者单位
1.Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci, CAS Key Lab Nutr Metab & Food Safety, Shanghai, Peoples R China
2.Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai, Peoples R China
3.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
4.Huzhou Univ, Peoples Hosp 1, Dept Surg, Huzhou, Peoples R China
5.Southern Med Univ, Fengxian Hosp, Dept Gen Surg, Shanghai, Peoples R China
6.Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China
7.China Natl Ctr Food Safety Risk Assessment, NHC Key Lab Food Safety Risk Assessment, Beijing, Peoples R China
通讯作者单位生命科学与技术学院
推荐引用方式
GB/T 7714
Gao, Hong,Yin, Fen-Fen,Guan, Dong-Xian,et al. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling[J]. CELL PROLIFERATION,2019,52(3).
APA Gao, Hong.,Yin, Fen-Fen.,Guan, Dong-Xian.,Feng, Yu-Xiong.,Zheng, Qian-Wen.,...&Xie, Dong.(2019).Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling.CELL PROLIFERATION,52(3).
MLA Gao, Hong,et al."Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of beta-catenin/TCF/LEF signalling".CELL PROLIFERATION 52.3(2019).
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Gao, Hong]的文章
[Yin, Fen-Fen]的文章
[Guan, Dong-Xian]的文章
百度学术
百度学术中相似的文章
[Gao, Hong]的文章
[Yin, Fen-Fen]的文章
[Guan, Dong-Xian]的文章
必应学术
必应学术中相似的文章
[Gao, Hong]的文章
[Yin, Fen-Fen]的文章
[Guan, Dong-Xian]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 10.1111@cpr.12583.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。